Clinical TrialsSearch results
Number of results: 253
Other
- Randomized, double-blind, placebo-controlled multi center clinical trial for the prevention of chronic lung disease in extremely low birth weight infants with inhaled fluticasone propionate
- chronic lung disease in extremely low birth weight infants
- Neonatal Research Network Japan
- 2006-04-12
Other
- NPB-01(intravenous immunoglobulin)therapy for patients with pemphigus unresponsive to corticosteroids:Multi-center,Randomized,Double-Blind ,Placebo Control,Parallel Assignment Study to examine dose response and efficacy of NPB-01.(Phase2+3)
- Pemphigus
- NIHON PHARMACEUTICAL CO.,LTD
- 2006-12-01
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Other
- Program of Angiotensin-Neprilysin Inhibition in Admitted Patients with Worsening Heart Failur
- Worsening heart failure with both signs of congestion and symptoms of heart failure
- Node Koichi
- 2021-11-15
Other
- Effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease
- type 2 diabetes and chronic kidney disease
- Node Koichi
- 2023-06-22
Other
- Phase II study of irinotecan and tegafur gimeracil for NSCLC with EGFR mutation which resistant to EGFR-TKI
- Non-small-cell lung cancer
- North Japan Lung Cancer Study Group
- 2010-08-31
Other
- Efficacy and safety of maintenance intravitreous injections of pegaptanib sodium every 6 weeks for 48 weeks in subjects with subfoveal neovascular Age-Related Macular Degeneration (AMD) initially treated with a modality resulting in maculopathy improvement: An exploratory study in a clinical setting
- Age-related macular degeneration
- NPO HEART
- 2009-03-31
Other
- Randomized pilot study comparing safety of irinotecan+S-1(IRIS)+bevacizumab and mFOLFIRI+bevacizumab for metastatic colorectal cancer (T-CORE0702)
- 1st line or 2nd line therapy for unresectable colorectal cancer
- NPO T-CORE (Tohoku Clinical Oncology Research and Education Society)
- 2007-07-22
Other
- Phase II trial of cetuximab plus irinotecan for FOLFOX and FOLFIRI-refractory patients with EGFR-positive advanced and/or metastatic colorectal cancer, evaluation of the safety and efficacy based on KRAS mutation status (T-CORE0801)
- 3rd line or later therapy for unresectable advanced and/or recurrent colorectal cancer
- NPO T-CORE (Tohoku Clinical Oncology Research and Education Society)
- 2009-01-31